Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib
文献类型：期刊论文
| 作者 | Wang, Deping; Feng, Yubing; Zhuang, Xiaoxi; Zhang, Fengxiang; Liu, Jianqi; Leng, Fang; Lang, Xingfen; Bai, Yang; She, Miaoqin; Tu, Zhengchao |
| 刊名 | JOURNAL OF MEDICINAL CHEMISTRY
 |
| 出版日期 | 2013 |
| 卷号 | 56期号:3 |
| ISSN号 | 0022-2623 |
| 学科主题 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| 源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/274]  |
| 专题 | 中国科学院广州生物医药与健康研究院 |
| 推荐引用方式 GB/T 7714 | Wang, Deping,Feng, Yubing,Zhuang, Xiaoxi,et al. Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib[J]. JOURNAL OF MEDICINAL CHEMISTRY,2013,56(3). |
| APA | Wang, Deping.,Feng, Yubing.,Zhuang, Xiaoxi.,Zhang, Fengxiang.,Liu, Jianqi.,...&Ren, Xiaomei.(2013).Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib.JOURNAL OF MEDICINAL CHEMISTRY,56(3). |
| MLA | Wang, Deping,et al."Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib".JOURNAL OF MEDICINAL CHEMISTRY 56.3(2013). |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。